A Morbidity-Mortality and Remodeling Study With Valsartan
Status:
Unknown status
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The JIKEI HEART Study has been designed to investigate whether concomitant treatment with
valsartan, an angiotensin II receptor blocker (ARB), in addition to conventional treatment,
will improve the prognosis of 3000 Japanese patients with cardiovascular diseases.